Navigation Links
Stem Cells Found In Cerebellum; Possible Cell of Origin for Childhood Brain Tumors

cerous growth, said Lee. Other research teams have shown that certain genes are mutated in medulloblastoma, but it has not been clear in which particular cells these genes are mutated.

The Duke team hopes to develop animal models in which they alter genes in neural stem cells and determine whether these alterations give rise to tumors. The goal is to identify the most crucial genes involved in medulloblastoma, and then develop drugs to disrupt these genes, said Wechsler-Reya.

"If we found a gene specific to tumor cells, we could develop an agent to shut down its activity without disrupting the growth of normal cells," he said. "Chemotherapy targets all dividing cells ?not just those involved in cancer ?so it is highly toxic. Our hope is to provide the basis for less toxic, more targeted therapies."


'"/>

Source:Duke Health


Page: 1 2 3

Related biology news :

1. Jump-starting T Cells In Skin Cancer
2. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
3. Transplantation Of Monkey Embryonic Stem Cells Reverses Parkinson Disease In Primates
4. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
5. Weill Cornell Research Reveals Secrets Of Trafficking Within Cells
6. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
7. Placenta Is A Rich Source Of Blood Stem Cells
8. UCSD Discovery Shows How Embryonic Stem Cells Perform Quality Control Inspections
9. Estrogen-like Component of Plastic Stimulates Growth of Certain Prostate Cancer Cells
10. Protein That Promotes Survival Of Stem Cells Might Be Key To Poor Leukemia Prognosis
11. Infants With Rare Genetic Disease Saved by Cord Blood Stem Cells

Post Your Comments:
(Date:11/30/2009)...us,s exquisite specialisation for its human host ...he humble lab mouse, can deliver only limited info...Med Central,s open access Journal of Biology hav...ating a mouse that has key features of HIV infecti...siotis, from the Division of Immunoregulation at M...
(Date:11/30/2009)...0 Neurotechnology ( http://www.neu...iometric identification technologies, has released...ne: VeriLook 4.0 Software Development Kit (SDK) ...or large-scale multi-biometric and automated finge...abilities in VeriLook 4.0 provide enhanced facial ...
(Date:11/26/2009)...er have been caught in the hunters, sights for gen...decorative. They are lethal weapons that stags cra...niversity of York, UK, has been intrigued by the m...ry and has become fascinated by the mechanical pro...ation with Tomas Landete-Castillejos at the Univer...
Breaking Biology News(10 mins):A reductionist approach to HIV research 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 3Tough yet stiff deer antler is materials scientist's dream 2Rodent size linked to human population and climate change 9434 1Rodent size linked to human population and climate change 9434 2Free Compirion Webinar Promotes Nurse Rounding to Improve Patient Safety 53306 1Free Compirion Webinar Promotes Nurse Rounding to Improve Patient Safety 53306 2Free Compirion Webinar Promotes Nurse Rounding to Improve Patient Safety 53306 3British Woman Celebrates a Year of Living Cancer Free 4803 1British Woman Celebrates a Year of Living Cancer Free 4803 2British Woman Celebrates a Year of Living Cancer Free 4803 3British Woman Celebrates a Year of Living Cancer Free 4803 4
...ous in the early 1980s when they stumbled on small...not only were they not supposed to be there, but t...taching to and detaching from proteins, effectivel...dom was that the job of turning proteins on and of... phosphates, in a common and easy-to-detect chemi...
...t Wake Forest University School of Medicine may be...ntraceptive use dramatically lowers the risk of ov... studying the effect of post-menopausal dietary so... monkeys, Latanya M. Scott, Ph.D., discovered that...in life had a reduced amount of estrogen excreted ...
...oratories engineer, and Bruce Osborn, chief operat... honored with a Popular Mechanics magazine Breakth... the Hearst Tower in New York City. , Sponsored b...lebrate innovations poised to change the world and...ES award is among 21 given by the magazine at the ...
Other Biology News:Johns Hopkins researchers detect sweet cacophony while listening to cellular cross-talk 2Birth control has long-term effect on hormone exposure 2Sandia, SES win Popular Mechanics Breakthrough Innovator Award 2
(Date:11/30/2009)... Minn., Nov. 30 Acuo Technologies,...gement software, data migration tools and services...s and Clinics for a new Vendor Neutral Archive (VN...ss the Allina network of hospitals, clinics and af... the Acuo Technologies DICOM Services Grid(TM) Sof...
(Date:11/30/2009)... 30 Dr. Jessica Torrente, Assistan...ersity Medical Center in Washington, D.C., demonst...amma Imaging (BSGI) in clinical practice as an adj...cancer today at the annual meeting of the Radiolog...urpose of the exhibit was to demonstrate how BSGI ...
(Date:11/30/2009)...E, Nov. 30 Cell Therapeu...today that its new class of platinum-based anti-tu... a stronger anti-tumor potency and activity compar... as well as the ability to overcome cisplatin-resi...sented in a paper titled "Novel Bis-platinum Compl...
(Date:11/29/2009)...able in German . , The concept of confineme...The most famous example is that of quarks which bi.... Bella Lake from Helmholtz-Zentrum Berlin togethe...for the first time an experimental realization and...ondensed matter system. , The concept of confine...
Breaking Biology Technology:Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 3Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3Spinons -- confined like quarks 2
..., SEATTLE, May 8 Dendreon Corporation (Nasdaq: ...ten public offering of 10,700,000 shares of its co...sole manager for the offering. Dendreon has grant...e an additional 1,279,166 shares of common stock t...ntends to use the net proceeds of the offering to ...
..., Conference Call Scheduled Today at 4:30pm ET ,...Expected in 1H 2009 , , Company to Provide Up...ll Today , , Corporate Highlights: , , - ... of Qutenza(TM) (formerly NGX-4010) for treatment ...lts, either alone or in combination with other med...
..., -- Management to host call and webcast today at ... recent business highlights -- , , SAN DIEGO, M...EX ), a biopharmaceutical company focused on the t...ancial results for the three months ended March 31..., As of March 31, 2009, Orexigen held $19.8 millio...
Other Biology Technology:Dendreon Announces Common Stock Offering 2NeurogesX Reports First Quarter 2009 Results 2NeurogesX Reports First Quarter 2009 Results 3NeurogesX Reports First Quarter 2009 Results 4NeurogesX Reports First Quarter 2009 Results 5NeurogesX Reports First Quarter 2009 Results 6NeurogesX Reports First Quarter 2009 Results 7NeurogesX Reports First Quarter 2009 Results 8NeurogesX Reports First Quarter 2009 Results 9NeurogesX Reports First Quarter 2009 Results 10NeurogesX Reports First Quarter 2009 Results 11Orexigen(R) Therapeutics Announces First Quarter 2009 Financial Results 2Orexigen(R) Therapeutics Announces First Quarter 2009 Financial Results 3Orexigen(R) Therapeutics Announces First Quarter 2009 Financial Results 4Orexigen(R) Therapeutics Announces First Quarter 2009 Financial Results 5Orexigen(R) Therapeutics Announces First Quarter 2009 Financial Results 6Orexigen(R) Therapeutics Announces First Quarter 2009 Financial Results 7Orexigen(R) Therapeutics Announces First Quarter 2009 Financial Results 8Orexigen(R) Therapeutics Announces First Quarter 2009 Financial Results 9
Donor feline Serum - 100mL from Biomeda Corporation
Monocyte Activation Kit from 3H Biomedical AB
Goat Anti-NPT1 (M-19) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Suction Cups and Assemblies from Parker Hannifin Corporation
Biology Products: